trending Market Intelligence /marketintelligence/en/news-insights/trending/JSfXwN6yKSKRV2YAzwJhnQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Elite files abbreviated new drug application for pain reliever

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Elite files abbreviated new drug application for pain reliever

Elite Pharmaceuticals Inc. submitted an abbreviated new drug application to the U.S. FDA for a generic version of Norco, a pain relief drug.

According to IMS Health data, total annual U.S. sales for combination products of hydrocodone and acetaminophen are about $700 million.